Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL) — Form 8-K: Current report
About this filing
Anavex Life Sciences Corp. (AVXL) filed an 8-K on Sep 28, 2026 reporting a change in control (Item 5.01) and shareholder vote results (Item 5.07).
Key facts
- Item 5.01 · Change in control
- Item 5.07 · Shareholder vote results
More AVXL filings
- 8-K
Filed Oct 20, 2026
- 8-K
Filed Oct 15, 2026
- 3
Filed Oct 5, 2026
- 3
Filed Oct 5, 2026
- 4
Filed Sep 28, 2026
- DFAN14A
Filed Sep 18, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.